Prof. Hockertz warns of a million times willful bodily harm | first published on July 17, 2020

Immune to SARS-COV-2 – finally – thanks to an emergency vaccination. That is exactly what large parts of the population – and the government – want right now. Pharmaceutical companies are being given considerable support to advance the goal of a corona vaccination as quickly as possible. But how quickly is ethically justifiable? How many risks are being hidden because of the speed of development? Professor STEFAN HOCKERTZ, a biologist, pharmacologist and toxicologist, points out a number of unanswered questions and warns that millions of people will intentionally submit themselves to bodily harm if these questions are not answered ahead of time. Dr. Stefan Hockertz was director and professor of the Institute for Experimental and Clinical Toxicology at the University Medical Center Hamburg Eppendorf from 2003 to theend of 2004. Before that, he was a member of the board of directors of the Fraunhofer Institute for Toxicology and Environmental Medicine in Hamburg from 1995 to 2002. From 1986 to 2001 he was a researcher at the Fraunhofer Society in Hanover. Hockertz completed his first training as a biologist in 1985. Prof. Stefan W. Hockertz is appointed eurotox-registered toxicologist. He is also Dr. rer. nat. in biology at the University of Hanover, qualified as a professor in toxicology and pharmacology at the University of Hamburg, and professor for molecular immunotoxicology at the University Medical Center Hamburg Eppendorf. Today he is managing partner of tpi consult GmbH, one of the leading toxicological and pharmacological technology consultancies in Europe.
First published in German on July 17, 2020 Translation and speaker: John JJ Jones Interview: Eva Schmidt The manuscript of the interview can be found on our website at:…erletzung.html

Ønsker du modtage OOCs nyhedsbrev, send venligst mail med teksten i emnefeltet: “Nyhedsbrev” til

Kontakt og medlemskab

OOC – Foreningen til Oplysning om Corona

Att. formand Søren Ventegodt

Bliv medlem – det koster 200 kr om året for individer og 1000 kr om året for virksomheder.

Mere information og link til betaling